UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in ...

Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?

Procept Biorobotics Corp. (($PRCT)) announced an update on their ongoing clinical study. Study Overview: The WATER IV Prostate Cancer study, ...

Q3 2025 Earnings Call Transcript October 29, 2025 AxoGen, Inc. beats earnings expectations. Reported EPS is $0.12, ...

“The latest results show that PSA screening in this trial prevented 22 prostate cancer deaths per 10,000 men screened, compared to 14 deaths in the previous analysis. It also shows that the harms of ...

This convergence of natural killer cell activation, T-cell engagers, personalized vaccines, and precision delivery systems positions ... of prostate cancer where eligible patients now have a ...

The Hugo Surgical Robot from Medtronic is a new system for robot-assisted surgery, aiming to make procedures less invasive. It’s designed with features like independent robotic arms and a 3D view to ...

Biomarker-driven approaches enhance the likelihood of identifying optimal patient populations and streamline trials through accelerated approval pathways, with FDA approvals incorporating increasingly ...

The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.

MISSOULA — Last October, Missoula’s Jim Van Fossen traveled to Ohio for prostate surgery. The procedure could easily have been done in Missoula, but Ohio offered something Missoula didn’t — the da ...